Angiodynamic Inc (ANGO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Angiodynamic Inc Stock (ANGO) Company Profile

Angiodynamic Inc

Healthcare (1111)

(518) 798-1215

14 PLAZA DRIVE, LATHAM

@angiodynamics

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ANGO's Discussions on Twitter

Compare ANGO vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ANGO Angiodynamic Inc	10.97	454.63M	307.31M	-27.71M	-15.27M	-0.6732
ISRG Intuitive Surgical Inc	485.84	169.97B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	175.89	50.58B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	79.20	38.58B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	44.55	37.11B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	252.55	35.80B	5.40B	1.49B	1.78B	10.12

Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-16	Eingeleitet	Lake Street	Buy
2024-04-05	Hochstufung	Oppenheimer	Perform → Outperform
2023-09-25	Eingeleitet	H.C. Wainwright	Buy
2023-04-17	Herabstufung	Raymond James	Strong Buy → Outperform
2021-10-15	Hochstufung	Canaccord Genuity	Hold → Buy
2021-08-20	Eingeleitet	Oppenheimer	Perform
2020-11-25	Hochstufung	Raymond James	Mkt Perform → Strong Buy
2020-04-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2019-04-01	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2018-04-03	Hochstufung	Raymond James	Mkt Perform → Outperform
2018-01-05	Herabstufung	Craig Hallum	Buy → Hold
2017-04-07	Bestätigt	Cantor Fitzgerald	Overweight
2017-03-30	Herabstufung	KeyBanc Capital Mkts	Overweight → Sector Weight
2017-02-08	Eingeleitet	Barclays	Equal Weight
2016-11-04	Eingeleitet	Cantor Fitzgerald	Buy
2016-04-08	Fortgesetzt	Piper Jaffray	Neutral
2016-01-08	Bestätigt	Canaccord Genuity	Buy
2015-11-10	Herabstufung	Raymond James	Outperform → Mkt Perform
2015-07-24	Eingeleitet	KeyBanc Capital Mkts	Overweight
2014-06-19	Hochstufung	Canaccord Genuity	Hold → Buy
2012-10-09	Bestätigt	Canaccord Genuity	Hold
2012-06-25	Herabstufung	Canaccord Genuity	Buy → Hold
2011-07-15	Hochstufung	Canaccord Genuity	Hold → Buy
2011-07-15	Hochstufung	Stifel Nicolaus	Hold → Buy
2011-06-14	Herabstufung	Wedbush	Neutral → Underperform
2010-09-08	Bestätigt	Wedbush	Neutral

Alle ansehen

Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten

Finanzdaten der Angiodynamic Inc-Aktie (ANGO)

Angiodynamic Inc (ANGO)

Angiodynamic Inc Stock (ANGO) Company Profile

Compare ANGO vs ISRG, BDX, ALC, MDLN, RMD

Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades

Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten

DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - Finviz

Is AngioDynamics Inc. stock influenced by commodity prices2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru

Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat

Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz

Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz

Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz

Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz

Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews

Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn

Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn

RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.

Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn

AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView

AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com

3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st

How AngioDynamics Inc. stock reacts to oil pricesJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда

Earnings Beat: Why AngioDynamics Inc. stock is seen as undervaluedWeekly Investment Report & Entry Point Confirmation Alerts - Улправда

Is AngioDynamics Inc. stock a defensive play in 2025Portfolio Risk Report & Low Risk Entry Point Tips - Улправда

Why AngioDynamics Inc. stock is seen as undervaluedMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда

Why AngioDynamics Inc. (UG2) stock remains top rated2025 Dividend Review & High Win Rate Trade Tips - Улправда

Will AngioDynamics Inc. stock benefit from commodity prices2025 Short Interest & Accurate Buy Signal Alerts - ulpravda.ru

Why AngioDynamics Inc. stock is recommended by analystsJuly 2025 Selloffs & Smart Allocation Stock Tips - Улправда

Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns? - Yahoo Finance

AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey

AngioDynamics Q2 Earnings Call Highlights - Defense World

ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets

AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8% - AlphaStreet

Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - ulpravda.ru

AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga

Aug Decliners: Will AngioDynamics Inc stock benefit from AI adoptionBear Alert & Accurate Entry/Exit Alerts - moha.gov.vn

AngioDynamics Vortex Failure Led to Port Catheter Removal, Lawsuit - AboutLawsuits.com

AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm

AngioDynamics (ANGO) to Release Earnings on Tuesday - Defense World

AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha

Trend Recap: Why AngioDynamics Inc UG2 stock remains top ratedTrade Exit Summary & Low Risk High Reward Trade Ideas - moha.gov.vn

AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? - Yahoo Finance

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz

Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan

New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan

Why AngioDynamics Inc. stock remains on buy listsWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber

Will AngioDynamics Inc. stock attract more institutional investorsSwing Trade & Growth Focused Stock Pick Reports - Улправда

How rising interest rates impact AngioDynamics Inc. stockTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда

How the Printed Matter Doctrine Sees Through X-Ray Markers - Patently-O

PATENT—Fed. Cir.: Bard’s vascular access port patents properly invalidated despite prior jury verdict - VitalLaw.com

Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat

Finanzdaten der Angiodynamic Inc-Aktie (ANGO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ANGO